Filed pursuant to Rule 424(b)(3)
Registration Statements Nos. 333-110229 and 333-110972
PROSPECTUS SUPPLEMENT NO. 3
(TO PROSPECTUS DATED DECEMBER 11, 2003)
Up to 726,842 shares
Intuitive Surgical, Inc.
This prospectus supplement amends the prospectus dated December 11, 2003 and the supplements thereto dated December 29, 2004 and October 13, 2005 (together, the Prospectus) relating to the offer and sale from time to time by certain selling stockholders of up 726,842 shares of our common stock, par value $0.001 per share, issuable upon the exercise of warrants assumed by us in connection with our acquisition of Computer Motion, Inc. We will not receive any proceeds from the sale of the shares, but we may receive proceeds from the cash exercise of the warrants prior to those sales, which proceeds would be used for general corporate purposes. Please see Selling Stockholders and Plan of Distribution in the Prospectus for information about the selling stockholders and the manner of offering of the common stock. The selling stockholders and any broker-dealers who may participate in sales of the shares may use this prospectus supplement.
This prospectus supplement should be read in conjunction with, and may not be delivered or utilized without, the Prospectus, and this prospectus supplement is qualified by reference to the Prospectus, except to the extent that information provided by this prospectus supplement supersedes the information contained in the Prospectus.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus supplement is March 29, 2006.
The table of selling stockholders and related footnotes in the Selling Stockholders section of the Prospectus setting forth information on the ownership of shares of our common stock beneficially owned and offered under the Prospectus are amended as set forth below.
The selling stockholders listed below have not held any position or office with, and have not otherwise had a material relationship with, us or any of our affiliates within the past three years, other than as a warrant holder. The percentage ownership data is based on 36,470,224 shares of our common stock outstanding as of February 28, 2006.
Owned Prior to
the Offering (1)
the Offering (2)
D3 LifeScience Ltd(3)
|*||Represents less than 1% of the issued and outstanding shares.|
|(1)||The preceding table has been prepared based solely upon information furnished to us as of the date of this prospectus supplement by the selling stockholders listed above. The selling stockholders identified above may have sold, transferred or otherwise disposed of, in transactions exempt from the registration requirements of the Securities Act, all or a portion of its shares since the date on which the information in the preceding table is presented.|
|(2)||Assumes the sale of all shares offered hereby.|
|(3)||Formerly CC Life Sciences, Ltd.|
|(4)||Transferee of Pequot Navigator Offshore Fund, Inc. and Pequot Scott Fund, LP.|